Four dimensions in schizophrenia - 4D

Study identifier:NIS-NES-DUM-2008/2

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Prospective observational study about progress of subjective well-being sensation in schizophrenic patients

Medical condition

schizophrenia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

320

Study type

Observational

Age

18 Years - 65 Years

Date

Study Start Date: 01 Oct 2008
Primary Completion Date: 01 Sept 2009
Study Completion Date: 01 Sept 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2009 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria